Viewing Study NCT05016661


Ignite Creation Date: 2025-12-24 @ 1:01 PM
Ignite Modification Date: 2026-01-03 @ 6:43 PM
Study NCT ID: NCT05016661
Status: TERMINATED
Last Update Posted: 2024-09-20
First Post: 2021-08-17
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Extension Study of ABP-20001 to Evaluate Safety and Efficacy of Repeat Treatments of ABP-450 for Migraine Prevention
Sponsor: AEON Biopharma, Inc.
Organization:

Organization Data

Organization:
Class: INDUSTRY
Study ID: ABP-20002
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators

Collaborators

Name Class View
None INDUSTRY View